home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Gut Hormone Aids Malnourished Dialysis Patients

  April, 23 2009 8:17
your information resource in human molecular genetics

Daily treatment with the gut hormone ghrelin is effective in sustaining an improved appetite in patients on dialysis, suggests a study published online in Kidney International.

Malnutrition is a frequent and early feature of chronic kidney disease, and is also associated with increased mortality in dialysis patients. In most cases no cause of malnutrition can be identified, but it may indicate inadequate dialysis or co-morbidity.

Damien Ashby and colleagues found that daily subcutaneous application of the hormone, which regulates hunger through the hypothalamus, increased patients' appetites without changing energy expenditure. The hormone also had a temporary effect in reducing patients' blood pressure. Researchers hope that further investigation into long-term application of ghrelin can assist in providing a healthy diet to malnourished dialysis patients.

Author contact:

Damien R. Ashby (Hammersmith Hospital, London, UK)
E-mail: d.ashby@imperial.ac.uk

Abstract available online.

(C) Kidney International press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.